Real-world effectiveness and safety of ibrutinib in patients with chronic lymphocytic leukemia in Japan: the Orbit study

Tsuyoshi Muta, Yosuke Masamoto, Go Yamamoto, Shingo Kurahashi, Yoshihiro Kameoka, Shuichi Ota, Eri Matsuki, Kazutaka Ozeki, Takanori Toyama, Naoki Takahashi, Takahiro Kumode, Nobuyuki Aotsuka, Takuro Yoshimura, Hideto Tamura, Ai Omi, Kazuhiro Shibayama, Aki Watanabe, Yasushi Isobe, Kensuke Kojima, Jun Takizawa, Hirokazu Nagai, Junji Suzumiya, Sadao Aoki

Open source

DOI: 10.1007/s12185-024-03875-0
Published: 2024-11-26
Container: International Journal of Hematology
Publisher: Springer Science and Business Media LLC
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1007/s12185-024-03875-0,
  title = {Real-world effectiveness and safety of ibrutinib in patients with chronic lymphocytic leukemia in Japan: the Orbit study},
  author = {Tsuyoshi Muta and Yosuke Masamoto and Go Yamamoto and Shingo Kurahashi and Yoshihiro Kameoka and Shuichi Ota and Eri Matsuki and Kazutaka Ozeki and Takanori Toyama and Naoki Takahashi and Takahiro Kumode and Nobuyuki Aotsuka and Takuro Yoshimura and Hideto Tamura and Ai Omi and Kazuhiro Shibayama and Aki Watanabe and Yasushi Isobe and Kensuke Kojima and Jun Takizawa and Hirokazu Nagai and Junji Suzumiya and Sadao Aoki},
  year = {2024},
  journal = {International Journal of Hematology},
  doi = {10.1007/s12185-024-03875-0},
  url = {https://doi.org/10.1007/s12185-024-03875-0}
}

RIS

TY  - JOUR
TI  - Real-world effectiveness and safety of ibrutinib in patients with chronic lymphocytic leukemia in Japan: the Orbit study
AU  - Tsuyoshi Muta
AU  - Yosuke Masamoto
AU  - Go Yamamoto
AU  - Shingo Kurahashi
AU  - Yoshihiro Kameoka
AU  - Shuichi Ota
AU  - Eri Matsuki
AU  - Kazutaka Ozeki
AU  - Takanori Toyama
AU  - Naoki Takahashi
AU  - Takahiro Kumode
AU  - Nobuyuki Aotsuka
AU  - Takuro Yoshimura
AU  - Hideto Tamura
AU  - Ai Omi
AU  - Kazuhiro Shibayama
AU  - Aki Watanabe
AU  - Yasushi Isobe
AU  - Kensuke Kojima
AU  - Jun Takizawa
AU  - Hirokazu Nagai
AU  - Junji Suzumiya
AU  - Sadao Aoki
PY  - 2024
JO  - International Journal of Hematology
DO  - 10.1007/s12185-024-03875-0
UR  - https://doi.org/10.1007/s12185-024-03875-0
ER  -

APA

Muta, T., Masamoto, Y., Yamamoto, G., Kurahashi, S., Kameoka, Y., Ota, S., Matsuki, E., Ozeki, K., Toyama, T., Takahashi, N., Kumode, T., Aotsuka, N., Yoshimura, T., Tamura, H., Omi, A., Shibayama, K., Watanabe, A., Isobe, Y., Kojima, K., Takizawa, J., Nagai, H., Suzumiya, J., & Aoki, S. (2024). Real-world effectiveness and safety of ibrutinib in patients with chronic lymphocytic leukemia in Japan: the Orbit study. International Journal of Hematology. https://doi.org/10.1007/s12185-024-03875-0

Source records

crossref · retrieved 2026-09-27T02:28:13.270Z